Pluri (PLUR) Revenue (2011 - 2025)

Pluri (PLUR) reported Revenue of $198000.0 for Q4 2025, up 7.03% year-over-year from $185000.0 in Q4 2024, and down 37.34% quarter-over-quarter from $316000.0 in Q3 2025.

Pluri (PLUR) Revenue (2011 - 2025) Analysis & Trends

Pluri (PLUR) has 12 years of Revenue data on file, last reported at $198000.0 in Q4 2025.

  • Revenue for Q4 2025 came in at $198000.0, up 7.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.3 million (up 97.49% YoY), and the FY2025 annual result was $1.3 million, up 309.82% from the prior year.
  • Revenue declined to $198000.0 in Q4 2025 per PLUR's latest filing, from $316000.0 in the prior quarter.
  • Over five years, Revenue peaked at $427000.0 in Q1 2025 and troughed at $2000.0 in Q4 2022.
  • A 4-year average of $179800.0 and a median of $111000.0 in 2023 frame the typical range for Revenue.
  • On a YoY basis, Revenue climbed as much as 5150.0% in 2023 and fell as far as 62.82% in 2023.
  • A 4-year view of Revenue shows it stood at $2000.0 in 2022, then soared by 5150.0% to $105000.0 in 2023, then soared by 76.19% to $185000.0 in 2024, then grew by 7.03% to $198000.0 in 2025.
  • Business Quant data shows PLUR's Revenue at $198000.0 in Q4 2025, $316000.0 in Q3 2025, and $398000.0 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 5.21 Mn
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 306.30 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 2.99 Bn
9 Abivax 94.37 Bn 94.37 Bn - -
10 Pluri 21.39 Mn 21.87 Mn 86,000.00 198,000.00

Historic Data

Download Data
DateValue
Dec 31, 2025 198,000.00
Sep 30, 2025 316,000.00
Jun 30, 2025 398,000.00
Mar 31, 2025 427,000.00
Dec 31, 2024 185,000.00
Sep 30, 2024 326,000.00
Jun 30, 2024 96,000.00
Mar 31, 2024 71,000.00
Dec 31, 2023 105,000.00
Sep 30, 2023 54,000.00
Jun 30, 2023 111,000.00
Mar 31, 2023 87,000.00
Dec 31, 2022 2,000.00
Sep 30, 2022 87,000.00
Mar 31, 2022 234,000.00
Dec 31, 2019 23,000.00
Dec 31, 2018 50,000.00
Sep 30, 2018 4,000.00
Dec 31, 2017 50,000.00
Dec 31, 2015 2.75 Mn